|
Published by: Millennium Research
Published: Aug. 8, 2007
Table of Contents
- TABLE OF CONTENTS
- LIST OF EXHIBITS
- EXECUTIVE SUMMARY
- METHODOLOGY
- 1.0 US DIABETIC VASCULAR DISEASE TREATMENT DEVICE MARKET
- 1.1 Market Overview
- 1.2 Diabetes Mellitus
- 1.2.1 Patient Population
- 1.2.2 Diabetic Vascular Disease
- 1.2.3 Macrovascular Complications of Diabetes
- 1.2.3.1 Diabetic Coronary Artery Disease
- 1.2.4 Microvascular Complications of Diabetes
- 1.2.4.1 Diabetic Nephropathy
- 1.2.4.2 Diabetic Neuropathy
- 1.2.4.3 Diabetic Retinopathy
- 1.2.5 Market Drivers & Limiters
- 2.0 DIABETIC CORONARY REVASCULARIZATION MARKET
- 2.1 Market Overview
- 2.1.1 Diabetic Coronary Artery Disease
- 2.1.2 Treatment Options
- 2.1.2.1 Medical Management
- 2.1.2.2 Coronary Revascularization
- 2.1.3 PCI versus CABG in Patients with Diabetes
- 2.1.3.1 Ongoing Clinical Trials
- 2.2 Market Analysis
- 2.2.1 Coronary Revascularization Procedures
- 2.2.1.1 PCI
- 2.2.1.2 CABG Surgery
- 2.2.2 Market Forecast
- 2.2.2.1 Diabetic Coronary Stents
- 2.2.2.2 PTCA Balloon Catheters
- 2.2.2.3 Coronary Atherectomy Devices
- 2.2.3 Market Drivers & Limiters
- 2.3 Competitive Analysis
- 3.0 DIABETIC NEPHROPATHY MARKET
- 3.1 Market Overview
- 3.2 Diabetic Nephropathy
- 3.2.1 Diabetic ESRD
- 3.3 Market Analysis
- 3.3.1 Arteriovenous Access Procedures
- 3.3.1.1 Native AV Fistula
- 3.3.1.2 Synthetic AV Graft
- 3.3.1.3 Dialysis Catheter
- 3.3.2 AV Access Management
- 3.3.2.1 AV POBA Procedures
- 3.3.2.2 AV Thrombectomy Procedures
- 3.3.3 Market Forecast
- 3.3.3.1 Dialysis Catheters in Diabetic Hemodialysis Patients
- 3.3.3.2 Synthetic AV Grafts
- 3.3.3.3 PTA Balloon Catheters for AV Access Management
- 3.3.3.4 Thrombectomy Devices for AV Access Management
- 3.3.4 Market Drivers & Limiters
- 3.4 Competitive Analysis
- 4.0 DIABETIC NEUROPATHY MARKET
- 4.1 Market Overview
- 4.2 Diabetic Neuropathy
- 4.3 Market Analysis
- 4.3.1 Lower Extremity Revascularization Procedures
- 4.3.1.1 PV Stent Procedures
- 4.3.1.2 PTA Procedures
- 4.3.1.3 Peripheral Atherectomy Procedures
- 4.3.1.4 Lower Extremity Bypass Procedures
- 4.3.2 Market Forecast
- 4.3.2.1 PV Stents
- 4.3.2.2 PTA Balloon Catheters
- 4.3.2.3 Peripheral Atherectomy Devices
- 4.3.2.4 Synthetic Bypass Graft Market
- 4.3.3 Market Drivers & Limiters
- 4.4 Competitive Analysis
- List of Exhibits
- EXECUTIVE SUMMARY
- Exhibit 1: Diabetic Vascular Disease Treatment Device Market, US (US$), 2006每2012
- Exhibit 2: Diabetic Coronary Revascularization Procedures, as a % of Total, US, 2007 and 2012
- Exhibit 3: Diabetic Nephropathy Market, US (US$), 2006每2012
- Exhibit 4: Diabetic Neuropathy Market, as a % of Total, US, 2006每2012
- METHODOLOGY
- CHAPTER 1: US DIABETIC VASCULAR DISEASE TREATMENT DEVICE MARKET
- Exhibit 5: Diabetic Vascular Disease Treatment Device Market, US (US$), 2006每 2012 (Graphical Format)
- Exhibit 6: Diabetic Vascular Disease Treatment Device Market, US (US$), 2006每 2012 (Tabular Format)
- Exhibit 7: Total Prevalent and Diagnosed Cases of Diabetes Mellitus, by Type, US, 2006每2012
- Exhibit 8: Prevalent and Diagnosed Cases of Diabetic Nephropathy, Neuropathy, and Retinopathy, US, 2006每2012
- Exhibit 9: Drivers of the Diabetic Vascular Disease Treatment Device Market, US, 2007
- Exhibit 10: Limiters of the Diabetic Vascular Disease Treatment Device Market, US, 2007
- CHAPTER 2: DIABETIC CORONARY REVASCULARIZATION MARKET
- Exhibit 11: Diabetic Coronary Revascularization Market, US (US$), 2006每2012 (Graphical Format)
- Exhibit 12: Diabetic Coronary Revascularization Market, US (US$), 2006每2012 (Tabular Format)
- Exhibit 13: Ongoing Clinical Trials in Diabetic Coronary Revascularization
- Exhibit 14: Treatment Algorithm for Patients with Diabetic Coronary Artery Disease, US, 2007
- Exhibit 15: Total Coronary Revascularization Procedures, by Type, US, 2006每2012
- Exhibit 16: Diabetic Penetration in Coronary Revascularization Procedures, by Segment, US, 2006每2012
- Exhibit 17: Diabetic Coronary Revascularization Procedures, by Type, US, 2006每 2012
- Exhibit 18: Diabetic PCI Procedures, by Type, as a % of Total, US, 2006每2012
- Exhibit 19: Diabetic Stent Procedures, by Type, US, 2006每2012
- Exhibit 20: Diabetic Stent Procedures, by Device Type, US, 2006每2012
- Exhibit 21: Diabetic PTCA Balloon Procedures, by Type, 2006每2012
- Exhibit 22: Diabetic Coronary Atherectomy Procedures, by Subsequent PCI Treatment, US, 2006每2012
- Exhibit 23: Diabetic CABG Procedures, by Type, 2006每2012
- Exhibit 24: Diabetic Stent Market, by Device Type, US (US$), 2006每2012 (Tabular Format)
- Exhibit 25: Diabetic Stent Market Growth, by Device Type, US, 2007©\2012
- Exhibit 26: Diabetic Stent Market, US (US$), 2006每2012 (Graphical Format)
- Exhibit 27: Diabetic Coronary Stents, by Type, US, 2006每2012
- Exhibit 28: Diabetic PTCA Balloon Catheter Market, US (US$), 2006每2012
- Exhibit 29: Diabetic PTCA Balloon Catheter Market, US, 2006每2012
- Exhibit 30: Diabetic Coronary Atherectomy Market, US (US$), 2006每2012 (Graphical Format)
- Exhibit 31: Coronary Atherectomy Market, US (US$), 2006每2012 (Tabular Format)
- Exhibit 32: Drivers of the Diabetic Coronary Revascularization Market, US
- Exhibit 33: Limiters of the Diabetic Coronary Revascularization Market, US
- Exhibit 34: Leading Competitors in the Coronary Revascularization Market, US, 2007 (Tabular Format)
- CHAPTER 3: DIABETIC NEPHROPATHY
- Exhibit 38: Diabetic Nephropathy Market, US, 2006每2012
- Exhibit 39: Diabetic Nephropathy Market, US (US$), 2006每2012 (Tabular Format)
- Exhibit 35: Prevalent Cases of Diabetic Nephropathy, US, 2006每2012
- Exhibit 36: Prevalent Cases of Diabetic Nephropathy, by Severity, US, 2006每2012
- Exhibit 37: Prevalence and Incidence of ESRD and Diabetic ESRD, US, 2006每2012
- Exhibit 40: Prevalent Diabetic ESRD Population on Hemodialysis, by Mode of AV Access, US, 2006每2012
- Exhibit 41: Incident ESRD and Diabetic ESRD, by Initial Treatment Modality, US, 2006每2012
- Exhibit 42: Incident Diabetic ESRD Patients on Hemodialysis, by Mode of AV Access, as a % of Total US, 2006每2012
- Exhibit 43: Incident Diabetic Hemodialysis Patients with DC for Vascular Access, by DC Type, US, 2006每2012
- Exhibit 44: Treatment Algorithm for Incident Diabetic ESRD, US, 2007
- Exhibit 45: Treatment Algorithm for Prevalent Diabetic ESRD, US, 2007
- Exhibit 46: AV Access Management Procedures, US, 2006每2012
- Exhibit 47: AV POBA Procedures in Diabetic Patients, by Type of AV Access, US, 2006每2012
- Exhibit 48: DC Units in Incident Diabetic Patients, by DC Type, US, 2006每2012
- Exhibit 49: DC Units in Net Surviving Diabetic Patients from Previous Year, US,2006每2012
- Exhibit 50: DC Units in Graft/Fistula Revision Procedures, by Type of AV Access, US, 2006每2012
- Exhibit 51: DC Units in Prevalent Diabetic Hemodialysis Patients, by DC Type, US, 2006每2012
- Exhibit 52: Diabetic Dialysis Catheter Market, US, 2006每2012 (Graphical Format)
- Exhibit 53: Diabetic Dialysis Catheter Market, by Type, As a % of Total US, 2006每 2012
- Exhibit 54: Diabetic Dialysis Catheter Market Growth, by Type, US, 2007每2012
- Exhibit 55: Diabetic Synthetic AV Graft Market, US (US$), 2006每2012 (Graphical Format)
- Exhibit 56: Diabetic Synthetic AV Graft Market, US (US$), 2006每2012 (Tabular Format)
- Exhibit 57: Diabetic Arteriovenous PTA Balloon Catheter Market, US, 2006每2012 (Graphical Format)
- Exhibit 58: Diabetic Arteriovenous PTA Balloon Catheter Market, US, 2006每2012 (Tabular Format)
- Exhibit 59: Diabetic AV Thrombectomy Market, US (US$), 2006每2012 (Graphical Format)
- Exhibit 60: Diabetic AV Thrombectomy Market, US (US$), 2006每2012 (Tabular Format)
- Exhibit 61: Drivers of the Diabetic Nephropathy Market, US, 2007
- Exhibit 62: Limiters of the Diabetic Nephropathy Market, US, 2007
- Exhibit 63: Leading Competitors in the Diabetic Nephropathy Market, US, 2007
- CHAPTER 4: DIABETIC NEUROPATHY
- Exhibit 64: Diabetic Neuropathy Market, US, 2006每2012 (Graphical Format)
- Exhibit 65: Diabetic Neuropathy Market, US, 2006每2012 (Tabular Format)
- Exhibit 66: Treatment Algorithm for Incident Cases of Diabetic Lower Extremity Vascular Disease, US, 2007
- Exhibit 67: Diabetic ATK Revascularization Procedures, by Device Type, US, 2006每2012
- Exhibit 68: Diabetic BTK Revascularization Procedures, by Device Type, US, 2006每2012
- Exhibit 69: Total Diabetic Lower Extremity Revascularization Procedures, by Device Type, US, 2006每2012 (Tabular Format)
- Exhibit 70: Total Diabetic Lower Extremity Revascularization Procedures, by Device Type, US, 2006每2012 (Graphical Format)
- Exhibit 71: Lower Extremity Revascularization Procedures, as a % of Total, US, 2006每2012
- Exhibit 72: Diabetic PV Stent Market, US (US$), 2006每2012 (Graphical Format)
- Exhibit 73: Diabetic PV Stent Market, by Indication, US, 2006每2012 (Tabular Format)
- Exhibit 74: Diabetic PV Stent Market Growth, by Indication US, 2006每2012
- Exhibit 75: Diabetic PTA Balloon Catheter Market, US (US$), 2006每2012 (Graphical Format)
- Exhibit 76: Diabetic PTA Balloon Catheter Market, US (US$), 2006每2012 (Tabular Format)
- Exhibit 77: Diabetic Peripheral Atherectomy Device Market, US (US$), 2006每2012 (Graphical Format)
- Exhibit 78: Diabetic Peripheral Atherectomy Device Market, US (US$), 2006每2012 (Tabular Format)
- Exhibit 79: Diabetic Synthetic Bypass Graft Market, US (US$), 2006每2012 (Graphical Format)
- Exhibit 80: Diabetic Synthetic Bypass Grafts Market, by Indication, US (US$), 2006每2012 (Tabular Format)
- Exhibit 81: Drivers of the Diabetic Neuropathy Market, US, 2007
- Exhibit 82: Limiters of the Diabetic Neuropathy Market, US
- Exhibit 83: Leading Competitors in the Diabetic Neuropathy Market, US, 2007
AbstractMRG provides you with the most comprehensive and accurate market intelligence so that you can confi dently plan for the future. US Markets for Diabetes Management
2007 provides in-depth segmentation and analysis that allow you to capitalize on underlying trends. Furthermore, detailed unit sales, average selling prices, and revenue
forecasts, as well as competitor market shares, provide a strong quantitative basis for decision making. This report also allows you to assess opportunities and threats
through our detailed competitive and qualitative trend analysis.
ANSWERING YOUR QUESTIONS
- Complete diabetes coverage: Receive comprehensive coverage of the diabetes management treatments in
one report. The data have been drawn from multiple reports and then analyzed to provide a direct comparison of
percutaneous interventions with surgical treatment of diabetic vascular disease.
- Up-to-date information: Receive current prevalence rates, incidence rates, and procedure numbers for the major
vascular complications of diabetes, supplemented with detailed patient algorithms.
- Increased opportunities: Understand how the changing dynamics between arteriovenous fistula and graft access
procedures will impact the US vascular access device market.
- Progressive treatments: Find out how advances in percutaneous coronary intervention technology and surgical
techniques are revolutionizing the treatment strategies available to the expanding diabetic population.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
